<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-59582</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Usefulness of apraclonidine in the diagnosis of horner syndrome</dc:title>
<dc:description xml:lang="en">Case reports: We present four cases: two maleswith Horner Syndrome, who were diagnosed bymeans of apraclonidine 0.5% and cocaine 4% testsrespectively. Two children with anysocoria, one ofwhom had Horner Syndrome confirmed with apraclonidine1% and the other, in whom an apraclonidinetest ruled out this syndrome but in whom pilocarpine0.125% confirmed Adie&#146;s pupil.Discussion: Apraclonidine drops (1% and 0.5%)may aid in the diagnosis of Horner Syndrome andare easier to obtain than cocaine(AU)</dc:description>
<dc:creator>Fernández, FJ</dc:creator>
<dc:creator>Alias, E</dc:creator>
<dc:creator>Honrubia, FM</dc:creator>
<dc:creator>González, I</dc:creator>
<dc:creator>Pérez-Íñigo, MA</dc:creator>
<dc:creator>Ferrer, C</dc:creator>
<dc:creator>Díaz, S</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Casos clínicos: Se presentan cuatro casos: dosvarones adultos con Síndrome de Horner clínico,diagnosticados mediante el test de apraclonidina0,5% y el test de cocaína 4% respectivamente, y dosniños con anisocoria de los cuales, en uno de ellosel Síndrome de Horner se confirma con apraclonidina1% y en otro el test de apraclonidina 1% descartael Síndrome de Horner y el test de pilocarpina0,125% confirma una pupila tónica de Adie.Discusión: La apraclonidina al 1% y al 0,5% puedenorientar el diagnóstico de Síndrome de Horner,siendo más fáciles de obtener que la cocaína (AU)</dc:description>
<dc:source>Arch Soc Esp Oftalmol;84(2): 105-108, feb. 2009. ilus</dc:source>
<dc:identifier>ibc-59582</dc:identifier>
<dc:title xml:lang="es">El uso de apraclonidina en el diagnóstico del síndrome de Horner</dc:title>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d3025^s22073</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28095^s22057</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d2715</dc:subject>
<dc:subject>^d319^s22073</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d28095^s22016</dc:subject>
<dc:subject>^d24521^s22016</dc:subject>
<dc:subject>^d3070</dc:subject>
<dc:subject>^d11295</dc:subject>
<dc:type>article</dc:type>
<dc:date>200902</dc:date>
</metadata>
</record>
</ibecs-document>
